Cargando…
Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus
OBJECTIVE: Benaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that has been approved in the treatment of type 2 diabetes mellitus (T2DM). It is known to lead to significant weight loss, and it is hypothesized that changes in gut microbiota may play a significant role in such weight...
Autores principales: | Han, Chen-Yu, Ye, Xiao-Mei, Lu, Jia-Ping, Jin, Hai-Ying, Wang, Ping, Xu, Wei-Wei, Zhang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416789/ https://www.ncbi.nlm.nih.gov/pubmed/37577040 http://dx.doi.org/10.2147/DMSO.S418757 |
Ejemplares similares
-
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
por: Wu, Jiaqiang, et al.
Publicado: (2023) -
Effects of Electroacupuncture on Gut Microbiota and Fecal Metabolites in Rats with Poststroke Depression
por: Cai, Wa, et al.
Publicado: (2023) -
Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer
por: Lu, Xingbing, et al.
Publicado: (2023) -
Effect of Different Dietary Regimes on the Gut Microbiota and Fecal Metabolites of Père David’s Deer
por: Zhen, Junai, et al.
Publicado: (2022) -
Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis
por: Wang, Han, et al.
Publicado: (2023)